<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen M</submitter><funding>Center for Tobacco Products</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>583-588</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9852357</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>36(4)</volume><pubmed_abstract>Carcinogen and toxicant uptake by e-cigarette users have not been fully evaluated. In the study reported here, we recruited 30 e-cigarette users, 63 nonsmokers, and 33 cigarette smokers who gave monthly urine samples over a period of 4-6 months. Their product use status was confirmed by measurements of exhaled CO, urinary total nicotine equivalents, cyanoethyl mercapturic acid (CEMA), and total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Urinary biomarkers of exposure to the carcinogens acrolein (3-hydroxypropyl mercapturic acid, 3-HPMA), benzene (&lt;i>S&lt;/i>-phenyl mercapturic acid, SPMA), acrylonitrile (CEMA), and a combination of crotonaldehyde, methyl vinyl ketone, and methacrolein (3-hydroxy-1-methylpropyl mercapturic acid, HMPMA) were quantified at each visit. Data from subject visits with CEMA > 27 pmol/mL were excluded from the statistical analysis of the results because of possible unreported exposures to volatile combustion products such as secondhand cigarette smoke or marijuana smoke exposure; this left 22 e-cigarette users with 4 or more monthly visits and all 63 nonsmokers. Geometric mean levels of 3-HPMA (1249 versus 679.3 pmol/mL urine) were significantly higher (&lt;i>P&lt;/i> = 0.003) in e-cigarette users than in nonsmokers, whereas levels of SPMA, CEMA, and HMPMA did not differ between these two groups. All analytes were significantly higher in cigarette smokers than in either e-cigarette users or nonsmokers. The results of this unique multimonth longitudinal study demonstrate consistent significantly higher uptake of the carcinogen acrolein in e-cigarette users versus nonsmokers, presenting a warning signal regarding e-cigarette use.</pubmed_abstract><journal>Chemical research in toxicology</journal><pubmed_title>Increased Levels of the Acrolein Metabolite 3-Hydroxypropyl Mercapturic Acid in the Urine of e-Cigarette Users.</pubmed_title><pmcid>PMC9852357</pmcid><funding_grant_id>R50 CA211256</funding_grant_id><funding_grant_id>CA-203851</funding_grant_id><funding_grant_id>CA-077598</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>P30 CA077598</funding_grant_id><funding_grant_id>CA-211256</funding_grant_id><funding_grant_id>R01 CA203851</funding_grant_id><pubmed_authors>Niesen B</pubmed_authors><pubmed_authors>Lindgren BR</pubmed_authors><pubmed_authors>Thomson NM</pubmed_authors><pubmed_authors>Ikuemonisan J</pubmed_authors><pubmed_authors>Hatsukami DK</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>Hecht SS</pubmed_authors><pubmed_authors>Carmella SG</pubmed_authors><pubmed_authors>Luo X</pubmed_authors><pubmed_authors>Murphy SE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Increased Levels of the Acrolein Metabolite 3-Hydroxypropyl Mercapturic Acid in the Urine of e-Cigarette Users.</name><description>Carcinogen and toxicant uptake by e-cigarette users have not been fully evaluated. In the study reported here, we recruited 30 e-cigarette users, 63 nonsmokers, and 33 cigarette smokers who gave monthly urine samples over a period of 4-6 months. Their product use status was confirmed by measurements of exhaled CO, urinary total nicotine equivalents, cyanoethyl mercapturic acid (CEMA), and total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Urinary biomarkers of exposure to the carcinogens acrolein (3-hydroxypropyl mercapturic acid, 3-HPMA), benzene (&lt;i>S&lt;/i>-phenyl mercapturic acid, SPMA), acrylonitrile (CEMA), and a combination of crotonaldehyde, methyl vinyl ketone, and methacrolein (3-hydroxy-1-methylpropyl mercapturic acid, HMPMA) were quantified at each visit. Data from subject visits with CEMA > 27 pmol/mL were excluded from the statistical analysis of the results because of possible unreported exposures to volatile combustion products such as secondhand cigarette smoke or marijuana smoke exposure; this left 22 e-cigarette users with 4 or more monthly visits and all 63 nonsmokers. Geometric mean levels of 3-HPMA (1249 versus 679.3 pmol/mL urine) were significantly higher (&lt;i>P&lt;/i> = 0.003) in e-cigarette users than in nonsmokers, whereas levels of SPMA, CEMA, and HMPMA did not differ between these two groups. All analytes were significantly higher in cigarette smokers than in either e-cigarette users or nonsmokers. The results of this unique multimonth longitudinal study demonstrate consistent significantly higher uptake of the carcinogen acrolein in e-cigarette users versus nonsmokers, presenting a warning signal regarding e-cigarette use.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-22T09:53:31.126Z</modification><creation>2025-02-19T04:16:00.474Z</creation></dates><accession>S-EPMC9852357</accession><cross_references><pubmed>35858275</pubmed><doi>10.1021/acs.chemrestox.2c00145</doi></cross_references></HashMap>